Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016
Authors:
- 1 July 2016
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 129 (7) , 661-666
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Detection, evaluation, and treatment of severe and resistant hypertensionJournal of the American Society of Hypertension, 2014
- Systematic Review and Meta-Analysis of the Prevalence of Resistant Hypertension in Treated Hypertensive PopulationsAmerican Journal of Hypertension, 2014
- Hyperaldosteronism as a Common Cause of Resistant HypertensionAnnual Review of Medicine, 2013
- Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008Circulation, 2011
- Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant HypertensionAnnals of Internal Medicine, 2009
- Resistant Hypertension: Diagnosis, Evaluation, and TreatmentHypertension, 2008
- The role of aldosterone in resistant hypertension: Implications for pathogenesis and therapyCurrent Hypertension Reports, 2007
- Aldosterone and the Vasculature: Mechanisms Mediating Resistant HypertensionThe Journal of Clinical Hypertension, 2007
- Cardiovascular Outcome in Treated Hypertensive Patients with Responder, Masked, False Resistant, and True Resistant HypertensionAmerican Journal of Hypertension, 2005
- High prevalence of cardiac and extracardiac target organ damage in refractory hypertensionJournal Of Hypertension, 2001